7,831 results on '"leflunomide"'
Search Results
2. Leflunomide in Previously Treated Metastatic Triple Negative Cancers
3. Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement
4. Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy
5. Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease
6. Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma
7. Leflunomide-induced collagenous colitis: a case report and literature review.
8. Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis
9. Leflunomide in Mild COVID-19 Patients
10. CHronic Nonbacterial Osteomyelitis International Registry (CHOIR) (CHOIR)
11. Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations (NТО-RAS)
12. Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Conditions
13. Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
14. Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
15. Leflunomide-induced cardiac injury in adult male mice and bioinformatic approach identifying Nrf2/NF-κb signaling interplay.
16. Leflunomide in Patients With PTEN-null Advanced Solid Malignancies
17. Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders
18. Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial (SPEED)
19. Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood
20. Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
21. Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis
22. Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach
23. The temporal association between adverse drug reactions and antirheumatic drugs utilisation in Western Australia: a retrospective study from real-world data (1995–2015).
24. Rheumatoid arthritis epidemiology: a nationwide study in Poland.
25. Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica.
26. OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
27. Leflunomide Treatment Does Not Protect Neural Cells following Oxygen-Glucose Deprivation (OGD) In Vitro.
28. Leflunomide: A versatile additive for defect reduction, enhanced optoelectronic properties and environmental stability of perovskite films.
29. Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non‐associative immune‐mediated thrombocytopenia: 20 cases (2008‐2021).
30. Efficacy of Leflunomide Compared to Methotrexate in the Treatment of Moderate to Severe Plaques Psoriasis: A Randomized Controlled Clinical Trial
31. Resolution of Plaque Keratopathy in a Patient with Atopic Keratoconjunctivitis After Treatment with Leflunomide.
32. Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
33. Leflunomide for Henoch-Schonlein Purpura (Lef for HSP)
34. Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children (Lef for IPH)
35. Leflunomide Confers Rapid Recovery from COVID-19 and is Coupled with Temporal Immunologic Changes.
36. Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis
37. Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
38. Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial (LUMEN1)
39. Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis.
40. Electronic Microscopy aspects of experimentally induced chronic arthritis.
41. Comparison of outcomes of azathioprine, leflunomide and allergen avoidance in patients with patch test-positive pigmented contact dermatitis: a randomized comparative study.
42. Vulnerability of Store-Operated Calcium Entry to Inhibitors and Microenvironment in Cells of Different Breast Cancer Subtypes.
43. New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment.
44. Leflunomide as adjunct therapy for BK viremia management in pediatric kidney transplant recipients.
45. DRESS syndrome with multiorgan involvement and HHV‐6 reactivation in the absence of a drug trigger.
46. To Carry Out Anti-Arthritic Activity of Combination of Quercetin and Curcumin Using FCA (Freund's Complete Adjuvant) Induced Arthritis in Laboratory Rats.
47. Seasonal and Treatment-Related Variation in 25-Hydroxy Vitamin D Concentration in Patients with Rheumatoid Arthritis.
48. Characteristics and prevalence of clinical remission of rheumatoid arthritis in a nationwide study from Indonesia.
49. Leflunomide-induced collagenous colitis: a case report and literature review.
50. The Impact of Screening for BK Virus Infection on the Incidence of BK Virus Nephropathy in Kidney Transplant Recipients: A Single-center Experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.